Cellular Immune Response in Patients Immunized with Three Vaccine Doses of Different Vaccination Schemes Authorized by the Chilean Ministry of Health in January 2022

In December 2019, a case of atypical pneumonia was reported in Wuhan, China. It was named COVID-19 and caused by SARS-CoV-2. In a few months, scientific groups around the world developed vaccines to reduce the disease’s severity. The objective was to evaluate the humoral and cellular immune response...

Descripción completa

Detalles Bibliográficos
Autores principales: Tabilo Valenzuela, Paz Beatriz, Flores Balter, Gabriela, Saint-Pierre Contreras, Gustavo, Conei Valencia, Daniel, Moreno Calderón, Catalina, Bohle Venegas, Constanza, Guajardo Rivera, Marcia, Silva Ojeda, Francisco, Vial Covarrubias, Maria Jesus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030012/
https://www.ncbi.nlm.nih.gov/pubmed/35455024
http://dx.doi.org/10.3390/life12040534

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030012/
https://www.ncbi.nlm.nih.gov/pubmed/35455024
http://dx.doi.org/10.3390/life12040534

Ejemplares similares